{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:20:34Z","timestamp":1777044034700,"version":"3.51.4"},"reference-count":22,"publisher":"Galenos Yayinevi","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjo"],"DOI":"10.4274\/tjo.galenos.2025.47717","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T09:51:27Z","timestamp":1750845087000},"page":"112-119","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of 20% Autologous Platelet-Rich Plasma Versus Conventional Treatment in Moderate to Severe Dry Eye Patients"],"prefix":"10.4274","volume":"55","author":[{"given":"Shubhi","family":"Sachan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kshama","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satya Prakash","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/01.ico.0000214802.40313.fa","article-title":"Dysfunctional tear syndrome: a Delphi approach to treatment recommendations","volume":"25","author":"Behrens","year":"2006","unstructured":"1. Behrens A, Doyle JJ, Stern L, Chuck RS, McDonnell PJ, Azar DT, Dua HS, Hom M, Karpecki PM, Laibson PR, Lemp MA, Meisler DM, Del Castillo JM, O'Brien TP, Pflugfelder SC, Rolando M, Schein OD, Seitz B, Tseng SC, van Setten G, Wilson SE, Yiu SC; Dysfunctional tear syndrome study group. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea. 2006;25:900-907.","journal-title":"Cornea"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1179\/136485910X12647085215859","article-title":"Estimating the prevalence of dry eye among Indian patients attending a tertiary ophthalmology clinic","volume":"104","author":"Gupta","year":"2010","unstructured":"2. Gupta N, Prasad I, Jain R, D'Souza P. Estimating the prevalence of dry eye among Indian patients attending a tertiary ophthalmology clinic. Ann Trop Med Parasitol. 2010;104:247-255.","journal-title":"Ann Trop Med Parasitol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4103\/0974-620X.169910","article-title":"Prevalence and associated factors of dry eye: our experience in patients above 40 years of age at a Tertiary Care Center","volume":"8","author":"Shah","year":"2015","unstructured":"3. Shah S, Jani H. Prevalence and associated factors of dry eye: our experience in patients above 40 years of age at a Tertiary Care Center. Oman J Ophthalmol. 2015;8:151-156.","journal-title":"Oman J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","article-title":"TFOS DEWS II report executive summary","volume":"15","author":"Craig","year":"2017","unstructured":"4. Craig JP, Nelson JD, Azar DT, Belmonte C, Bron AJ, Chauhan SK, de Paiva CS, Gomes JAP, Hammitt KM, Jones L, Nichols JJ, Nichols KK, Novack GD, Stapleton FJ, Willcox MDP, Wolffsohn JS, Sullivan DA. TFOS DEWS II report executive summary. Ocul Surf. 2017;15:802-812.","journal-title":"Ocul Surf"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4103\/ijo.IJO_698_17","article-title":"Prevalence and risk factors of dry eye disease in North India: ocular surface disease index-based cross-sectional hospital study","volume":"66","author":"Titiyal","year":"2018","unstructured":"5. Titiyal JS, Falera RC, Kaur M, Sharma V, Sharma N. Prevalence and risk factors of dry eye disease in North India: ocular surface disease index-based cross-sectional hospital study. Indian J Ophthalmol. 2018;66:207-211.","journal-title":"Indian J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1160\/TH03-07-0440","article-title":"Autologous platelets as a source of proteins for healing and tissue regeneration","volume":"91","author":"Anitua","year":"2004","unstructured":"6. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004;91:4-15.","journal-title":"Thromb Haemost"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"102091","DOI":"10.1016\/j.clae.2023.102091","article-title":"Platelet-rich plasma for treating dry eye disease - a systematic review and meta-analysis","volume":"47","author":"Kwaku Akowuah","year":"2024","unstructured":"7. Kwaku Akowuah P, Junior Obinwanne C, Owusu E, Kyeremeh S, Bonsu K, Karikari LAA, Akyaa Akomeah F, Kyei Nkansah E, Kobia-Acquah E. Platelet-rich plasma for treating dry eye disease - a systematic review and meta-analysis. Cont Lens Anterior Eye. 2024;47:102091.","journal-title":"Cont Lens Anterior Eye"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Thulasi P, Djalilian AR. Update in current diagnostics and therapeutics of dry eye disease. Ophthalmology. 2017;124:S27-S33.","DOI":"10.1016\/j.ophtha.2017.07.022"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fmed.2018.00033","article-title":"Reflections on dry eye syndrome treatment: therapeutic role of blood products","volume":"5","author":"Drew","year":"2018","unstructured":"9. Drew VJ, Tseng CL, Seghatchian J, Burnouf T. Reflections on dry eye syndrome treatment: therapeutic role of blood products. Front Med (Lausanne). 2018;5:33.","journal-title":"Front Med (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000100933","article-title":"Symptomatic dry eye treatment with autologous platelet-rich plasma","volume":"39","author":"Alio","year":"2007","unstructured":"10. Alio JL, Colecha JR, Pastor S, Rodriguez A, Artola A. Symptomatic dry eye treatment with autologous platelet-rich plasma. Ophthalmic Res. 2007;39:124-129.","journal-title":"Ophthalmic Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1097\/ICO.0b013e31820d86d6","article-title":"Efficacy of plasma rich in growth factors for the treatment of dry eye","volume":"30","author":"L\u00f3pez-Plandolit","year":"2011","unstructured":"11. L\u00f3pez-Plandolit S, Morales MC, Freire V, Grau AE, Dur\u00e1n JA. Efficacy of plasma rich in growth factors for the treatment of dry eye. Cornea. 2011;30:1312-1317.","journal-title":"Cornea"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Garc\u00eda-Conca V, Abad-Collado M, Hueso-Abancens JR, Mengual-Verd\u00fa E, Pi\u00f1ero DP, Aguirre-Balsalobre F, Molina JC. Efficacy and safety of treatment of hyposecretory dry eye with platelet-rich plasma. Acta Ophthalmol. 2019;97:e170-e178.","DOI":"10.1111\/aos.13907"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.4103\/ijo.IJO_2595_21","article-title":"Autologous platelet-rich plasma eye drop versus artificial tear eye drop for symptomatic dry eye disease: a prospective comparative interventional study","volume":"70","author":"Rawat","year":"2022","unstructured":"13. Rawat P, Agrawal R, Bhaisare V, Walia S, Kori N, Gupta R. Autologous platelet-rich plasma eye drop versus artificial tear eye drop for symptomatic dry eye disease: a prospective comparative interventional study. Indian J Ophthalmol. 2022;70:1549-1553.","journal-title":"Indian J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1089\/jop.2016.0166","article-title":"The effect of immunologically safe plasma rich in growth factor eye drops in patients with Sj\u00f6gren syndrome","volume":"33","author":"Sanchez-Avila","year":"2017","unstructured":"14. Sanchez-Avila RM, Merayo-Lloves J, Riestra AC, Anitua E, Muruzabal F, Orive G, Fern\u00e1ndez-Vega L. The effect of immunologically safe plasma rich in growth factor eye drops in patients with Sj\u00f6gren syndrome. J Ocul Pharmacol Ther. 2017;33:391-399.","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000444496","article-title":"Safety and efficacy of autologous plasma rich in growth factors eye drops for the treatment of evaporative dry eye","volume":"56","author":"Merayo-Lloves","year":"2016","unstructured":"15. Merayo-Lloves J, Sanchez-Avila RM, Riestra AC, Anitua E, Bego\u00f1a L, Orive G, Fernandez-Vega L. Safety and efficacy of autologous plasma rich in growth factors eye drops for the treatment of evaporative dry eye. Ophthalmic Res. 2016;56:68-73.","journal-title":"Ophthalmic Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.21608\/ejhm.2021.180354","article-title":"Evaluating the role of autologous platelet-\u00acrich-plasma in the treatment of dry eye disease","volume":"84","author":"Emam","year":"2021","unstructured":"16. Emam DHF, El Mashad GY, Alkawas A, El Deen SMS. Evaluating the role of autologous platelet-\u00acrich-plasma in the treatment of dry eye disease. Egypt J Hosp Med. 2021;84:2065-2070.","journal-title":"Egypt J Hosp Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"9516","DOI":"10.1167\/iovs.11-8412","article-title":"Corneal fluorescein staining correlates with visual function in dry eye patients","volume":"52","author":"Kaido","year":"2011","unstructured":"17. Kaido M, Matsumoto Y, Shigeno Y, Ishida R, Dogru M, Tsubota K. Corneal fluorescein staining correlates with visual function in dry eye patients. Invest Ophthalmol Vis Sci. 2011;52:9516-9522.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jtos.2016.11.003","article-title":"Visual acuity and quality of life in dry eye disease: proceedings of the OCEAN group meeting","volume":"15","author":"Ben\u00edtez-Del-Castillo","year":"2017","unstructured":"18. Ben\u00edtez-Del-Castillo J, Labetoulle M, Baudouin C, Rolando M, Akova YA, Aragona P, Geerling G, Merayo-Lloves J, Messmer EM, Boboridis K. Visual acuity and quality of life in dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf. 2017;15:169-178.","journal-title":"Ocul Surf"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.2147\/OPTH.S367807","article-title":"Autologous platelet-rich plasma drops for evaporative dry eye disease from meibomian gland dysfunction: a pilot study","volume":"16","author":"Murtaza","year":"2022","unstructured":"19. Murtaza F, Toameh D, Chiu HH, Tam ES, Somani S. Autologous platelet-rich plasma drops for evaporative dry eye disease from meibomian gland dysfunction: a pilot study. Clin Ophthalmol. 2022;16:2199-2208.","journal-title":"Clin Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Avila MY, Igua AM, Mora AM. Randomised, prospective clinical trial of platelet-rich plasma injection in the management of severe dry eye. Br J Ophthalmol. 2018:bjophthalmol-2018-312072.","DOI":"10.1136\/bjophthalmol-2018-312072"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/archopht.1984.01040030851031","article-title":"Conjunctival goblet cell densities in ocular surface disease","volume":"102","author":"JD","year":"1984","unstructured":"21. Nelson JD, Wright JC. Conjunctival goblet cell densities in ocular surface disease. Arch Ophthalmol. 1984;102:1049-1051.","journal-title":"Arch Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1167\/iovs.13-12217","article-title":"The Ocular Redness Index: a novel automated method for measuring ocular injection","volume":"54","author":"Amparo","year":"2013","unstructured":"22. Amparo F, Wang H, Emami-Naeini P, Karimian P, Dana R. The Ocular Redness Index: a novel automated method for measuring ocular injection. Invest Ophthalmol Vis Sci. 2013;54:4821-4826.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Turkish Journal of Ophthalmology"],"original-title":[],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T07:02:08Z","timestamp":1753426928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oftalmoloji.org\/articles\/comparison-of-20percent-autologous-platelet-rich-plasma-versus-conventional-treatment-in-moderate-to-severe-dry-eye-patients\/doi\/tjo.galenos.2025.47717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6,25]]}},"URL":"https:\/\/doi.org\/10.4274\/tjo.galenos.2025.47717","relation":{},"ISSN":["1300-0659","2147-2661"],"issn-type":[{"value":"1300-0659","type":"print"},{"value":"2147-2661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]}}}